209 related articles for article (PubMed ID: 11662375)
1. The politics of deoxyribonucleic acid.
Budrys A
New Repub; 1977 Apr; 176(16):18-21. PubMed ID: 11662375
[No Abstract] [Full Text] [Related]
2. Can scientists be trusted on hazardous research?
Fields CM
Chron High Educ; 1976 Aug; 12(21):4-5. PubMed ID: 11661340
[No Abstract] [Full Text] [Related]
3. The regulation of recombinant DNA research: the alternative of local control.
Rosenblatt DP
Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
[No Abstract] [Full Text] [Related]
4. Recombinant DNA: legal responses to a new biohazard.
Balmer TA
Environ Law; 1977; 7(2):293-313. PubMed ID: 11661448
[No Abstract] [Full Text] [Related]
5. Science vs. the public.
Norman C
Nature; 1976 Jul; 262(5565):163-5. PubMed ID: 11643318
[No Abstract] [Full Text] [Related]
6. A science for the people.
King J
New Sci; 1977 Jun; 74(1056):634-6. PubMed ID: 11663772
[No Abstract] [Full Text] [Related]
7. Science that frightens scientists: the great debate over DNA.
Bennett W; Gurin J
Atl Mon; 1977 Feb; 237(2):43-50+. PubMed ID: 11661393
[No Abstract] [Full Text] [Related]
8. Gene transplants stir communities' fears; scientists are split.
Gumpert D
Wall St J (East Ed); 1976 Sep; ():1+. PubMed ID: 11649045
[No Abstract] [Full Text] [Related]
9. Genetic engineering: the people's choice.
Neustadtl SJ
Technol Rev; 1976 Dec; 79(2):10-11+. PubMed ID: 11661728
[No Abstract] [Full Text] [Related]
10. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
11. Science vs. politics in Boston.
Suzuki DT
Sci Forum; 1977 Jun; 10(3):16. PubMed ID: 11650573
[No Abstract] [Full Text] [Related]
12. Threat to US genetic engineering.
Chedd G
New Sci; 1976 Jul; 71(1007):14-5. PubMed ID: 11663684
[No Abstract] [Full Text] [Related]
13. Reasonableness versus rationality in the construction and justification of science policy decisions: the case of the Cambridge Experimentation Review Board.
Waddell C
Sci Technol Human Values; 1989; 14(1):7-25. PubMed ID: 11650830
[No Abstract] [Full Text] [Related]
14. Threats and promises: negotiating the control of research.
Nelkin D
Daedalus; 1978; 107(2):191-209. PubMed ID: 11645789
[No Abstract] [Full Text] [Related]
15. Risks and benefits, rights and responsibilities: a history of the recombinant DNA research controversy.
Swazey JP; Sorenson JR; Wong CB
South Calif Law Rev; 1978 Sep; 51(6):1019-78. PubMed ID: 11661650
[No Abstract] [Full Text] [Related]
16. Judgement of the people.
Norman C
Nature; 1977 Jan; 265(5590):98-9. PubMed ID: 11643358
[No Abstract] [Full Text] [Related]
17. Institutional biosafety committees and the inadequacies of risk regulation.
Bereano PL
Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
[No Abstract] [Full Text] [Related]
18. The perils of knitting new life.
Lappé M
Am Biol Teach; 1977 Apr; 39(4):200-206, 210. PubMed ID: 11650656
[No Abstract] [Full Text] [Related]
19. Recombinant DNA: triumph or Trojan horse?
Holtzman E
Man Med; 1977; 2(2):83-103, W7. PubMed ID: 12083131
[No Abstract] [Full Text] [Related]
20. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
